deaths from tirzepatide GROUNDBREAKING UPDATE! FDA has approved TIRZEPATIDE, a pioneering obesity treatment activating GIP & GLP-1 receptors, for weight loss! Previously, has been FDA approved for type 2 diabetes as Mounjaro, and although Tirzepatide similar to dulaglutide for

The Congressional Budget Office (CBO) estimates that expanding Medicare coverage for these drugs could increase federal spending by about $35 billion over the next decade

Make Protein the Star of Every Meal Protein is essentialit keeps you full, protects muscle mass, and helps your metabolism stay strong

We'll assess your health and discuss your goals

However, researchers continue to investigate the precise mechanisms underlying these broader metabolic improvements

The Plateau Problem - Why GLP-1 Therapies Stop Working (and What To Do About It) Share The Plateau Problem Why GLP-1 Therapies Stop Working (and What To Do About It) GLP-1 therapies like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have delivered remarkable results for many patientsbut for a growing number, theres a common frustration: It was working and then it wasnt. Weight loss slows

Semaglutide, which is typically used by adults with type II diabetes to control blood sugar, can also be prescribed for weight management in adults with obesity and at least one other health condition